Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.063 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.066 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |